Search results
Sensex breaches 79,000 mark, Nifty scales 24,000 peak in record-breaking rally
Indian Express· 7 days agoThe 30-share BSE Sensex jumped 568.93 points or 0.72 per cent to settle at a new closing peak of...
China: In a First, Two Former Defence Ministers to Be Tried for Corruption, Expelled from Communist...
News18· 6 days agoThe Communist Party headed by Xi, has expelled Gen. Wei, 70, and Gen. Li, 66, for alleged corruption...
In a first, two ex-Chinese defence ministers to be tried for corruption; Expelled from Communist...
Theprint· 7 days agoLi, who went missing last year following an investigation into alleged corrupt practices, was...
Stock market today: Sensex ends above 79k, Nifty 50 surpasses 24,000 for the first time led by...
Livemint· 7 days agoStock market today: Nifty 50 hits 24,000 for the first time, Sensex hits 79k briefly. It took 23...
Yen hits 38-year low, Nikkei surges as Trump risk buoys US yields - The Economic Times
The Economic Times· 2 days agoThe U.S. dollar hit a near 38-year high to the yen on Tuesday following a surge in Treasury yields...
Sensex Breaches 79,000 Level, Nifty Crosses 24,000 For 1st Time Ever
NDTV· 7 days agoSensex breached the historic 79,000 mark while Nifty scaled the 24,000 peak for the first time today...
Majority of debate watchers say Trump won debate over Biden: CNN Poll
Business Standard India· 6 days agoFormer US president Donald Trump turned in a better performance than President Joe Biden during the...
Debate upshots: Trump punches, even when wrong, Biden bows, even with facts
Business Standard India· 6 days agoThursday's presidential debate was a re-run that featured two candidates with a combined age of 159,...
FirstUp: New criminal laws in India, and more... The big news today
Firstpost· 3 days agoThree new criminal laws are set to be implemented from Monday, July 1. The results of the biennial...
PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar
BioPharma Dive· 6 days agoEuropean drug regulators voted for a third time not to renew the approval of Translarna. Elsewhere,...